Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome
Hormone and Metabolic Research · 01.09.2025 · 57 (09) · 529-534
DOI: 10.1055/a-2712-8064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.09.2025. Verfasst von Karynne Grutter Lopes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Clinical and Experimental Physiopathology (Fisclinex), Faculty of Medical Sciences, State University of Rio de Janeiro, Rio d…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Adipokines, Adiposity, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
The aim of this cross-sectional study was to compare and test associations between inflammatory profiles and liver steatosis/fibrosis in individuals with different degrees of adiposity with or without metabolic syndrome. Forty-six patients (82.6% females, aged 38.3±7.8 yr, body mass index of 32.6±5.1 kg/m2) were allocated into three groups according to body adiposity and the presence or absence of metabolic syndrome: normal-weight controls, patients with obesity or with obesity and metabolic syndrome. Between-group comparisons were performed for clinical history, anthropometry, biochemical, metabolic, and inflammatory profiles, and degree of liver stiffness and steatosis by transient elastography. As expected, obesity and obesity and metabolic syndrome had greater body mass index and waist circumference than controls. No significant differences between groups in lipid profile, aspartate aminotransferase, ferritin, adiponectin, and retinol-binding protein-4 were noted. Obesity and metabolic syndrome had significantly higher fasting glucose levels compared to controls and obesity. A more significant proportion of patients with hypertension, higher insulinemia, HOMA-IR, glycated hemoglobin, aspartate aminotransferase, gamma-glutamyltransferase, tumor necrosis factor-alpha, interleukin-6, and leptin were observed in obesity and metabolic syndrome compared to controls. Obesity had higher alkaline phosphatase, interleukin-6, and leptin levels than controls. Liver stiffness and steatosis were higher in obesity and metabolic syndrome than in controls, while hepatic fibrosis degree F2 occurred more frequently in obesity and metabolic syndrome (p≤0.03). No associations were detected between liver stiffness and steatosis and inflammatory biomarkers in the studied groups (p≥0.07). Our findings highlight the impact of metabolic conditions on liver health but also suggest that systemic inflammation might not be directly linked to liver stiffness and steatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Clinical and Experimental Physiopathology (Fisclinex), Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Laboratory for Clinical and Experimental Research on Vascular Biology (Biovasc), Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Obesity Unit, Multiuser Clinical Research Center (CePeM), Pedro Ernesto University Hospital (HUPE), State University of Rio de Janeiro, RJ, Brazil.
- Department of Physiological Sciences, Roberto Alcantara Gomes Biology Institute, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Gastroenterology, Department of Internal Medicine, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Endocrinology, Department of Internal Medicine, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
ORCID-Profile: Karynne Grutter Lopes, Maria das Graças Coelho de Souza, Fernanda de Azevedo Marques Lopes, Vicente Lopes da Silva Junior, Carlos Antonio Terra, Ana Teresa Pugas Carvalho, Eliete Bouskela, Luiz Guilherme Kraemer-Aguiar
Zitieren
APA
Lopes, K. G., Souza, M. D. G. C., Lopes, F. A. M., da Silva Junior, V. L., Terra, C. A., Carvalho, A. T. P., Bouskela, E., & Kraemer-Aguiar, L. G. (2025). Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome. Hormone and Metabolic Research, 57(09), 529-534. https://doi.org/10.1055/a-2712-8064
Vancouver
Lopes KG, Souza MDGC, Lopes FAM, da Silva Junior VL, Terra CA, Carvalho ATP, et al. Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome. Hormone and Metabolic Research. 2025;57(09):529-534. doi:10.1055/a-2712-8064
BibTeX
@article{Lopes2025,
author = {Lopes, Karynne Grutter and Souza, Maria das Graças Coelho de and Lopes, Fernanda de Azevedo Marques and da Silva Junior, Vicente Lopes and Terra, Carlos Antonio and Carvalho, Ana Teresa Pugas and Bouskela, Eliete and Kraemer-Aguiar, Luiz Guilherme},
title = {Associations Between Inflammatory Adipokines, Liver Steatosis, and Fibrosis in Patients with Different Degrees of Adiposity with or Without Metabolic Syndrome},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {09},
pages = {529--534},
doi = {10.1055/a-2712-8064}
}
EUVIMED